0001193805-24-000065.txt : 20240119
0001193805-24-000065.hdr.sgml : 20240119
20240119160538
ACCESSION NUMBER: 0001193805-24-000065
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240119
DATE AS OF CHANGE: 20240119
EFFECTIVENESS DATE: 20240119
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNIC, INC.
CENTRAL INDEX KEY: 0001280776
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 562358443
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-502974
FILM NUMBER: 24545604
BUSINESS ADDRESS:
STREET 1: 1200 AVENUE OF THE AMERICAS
STREET 2: SUITE 200
CITY: NEW YORK
STATE: X1
ZIP: 10036
BUSINESS PHONE: (332) 255-9818
MAIL ADDRESS:
STREET 1: 1200 AVENUE OF THE AMERICAS
STREET 2: SUITE 200
CITY: NEW YORK
STATE: X1
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: VITAL THERAPIES INC
DATE OF NAME CHANGE: 20040219
D
1
primary_doc.xml
X0708
D
LIVE
0001280776
IMMUNIC, INC.
1200 AVENUE OF THE AMERICAS, SUITE 200
NEW YORK
X1
UNITED STATES
10036
(332) 255-9818
DELAWARE
Vital Therapies, Inc.
VITAL THERAPIES INC
Corporation
true
Daniel
Vitt
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Executive Officer
Director
Duane
Nash
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Director
Executive chairman of board of directors
Tamar
Howson
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Director
Barclay
Phillips
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Director
Jorg
Neermann
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Director
Richard
Rudick
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Director
Andreas
Muehler
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Executive Officer
Patrick
Walsh
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Executive Officer
Maria
Tornsen
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Director
Hella
Kohlhof
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Executive Officer
Chief Scientific Officer
Glenn
Whaley
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Executive Officer
Inderpal
Singh
1200 Avenue of the Americas, Suite 200
New York
NY
NEW YORK
10036
Executive Officer
General Counsel
Biotechnology
No Revenues
- 06b
false
2024-01-04
true
true
true
true
false
0
None
None
Leerink Partners LLC
39011
1301 AVENUE OF THE AMERICAS
12TH FLOOR
NEW YORK
NY
NEW YORK
10019
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
IL
ILLINOIS
MA
MASSACHUSETTS
NY
NEW YORK
TX
TEXAS
false
None
None
Ladenburg Thalmann & Co. Inc.
505
640 5TH AVENUE, 4TH FLOOR
NEW YORK
NY
NEW YORK
10019
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
IL
ILLINOIS
MA
MASSACHUSETTS
NY
NEW YORK
TX
TEXAS
false
240000000
80000016
159999984
Offering to be sold in 3 tranches of $80,000,000 each, subject to specified conditions. Third tranche permits funding on a "cashless" or net exercise basis.
false
19
4800000
0
The sales commissions amount exclusively pertains to the total amount sold in the first tranche of this offering.
0
false
IMMUNIC, INC.
/s/ Glenn Whaley
Glenn Whaley
Chief Financial Officer
2024-01-19